The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
Emirati Field Hospital in Gaza completes complex tumour removal
UAE, Austria discuss ways to boost partnership
No parking fines in Sharjah's rain-hit areas
Sharjah students to return to on-site learning
Dubai sets up crisis management office to handle health emergencies
Dubai's bus-on-demand serves new route
UAE approves first vertiport for electric flying vehicles
UAE welcomes review report supporting UNRWA's 'crucial' performance
